Status:
UNKNOWN
After Eighty Study
Lead Sponsor:
Oslo University Hospital
Conditions:
Coronary Heart Disease
Eligibility:
All Genders
80+ years
Brief Summary
The rationale of the present clinical trial is to study whether an invasive strategy in clinical stable patients over 80 years with NSTEMI/UAP may improve rates of death, reinfarction, stroke, need of...
Eligibility Criteria
Inclusion
- Age ≥ 80 years.
- Acute coronary syndrome (NSTEMI/UAP) with chest pain \> 10 minutes, with or without ST-segment depression in ECG, and normal or elevated levels of troponin T or I. Elevated troponin levels are defined as values exceeding the 99 percentile of a normal population at the local laboratory at each participating site.
- Clinical stable
Exclusion
- Age \< 80 years.
- ST-segment elevation in ECG (STEMI)
- Clinical unstable with ongoing chest pain or other ischaemic symptoms/signs.
- Cardiogenic shock.
- Short life expectancy due to extra cardiac reason, ie. COPD, disseminated malignant disease, or other reason.
- Anamnestic indications for significant mental disorder, including dementia.
- Any condition which interferes with patients possibility to comply with protocol.
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2019
Estimated Enrollment :
492 Patients enrolled
Trial Details
Trial ID
NCT01255540
Start Date
December 1 2010
End Date
February 1 2019
Last Update
October 22 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital, Rikshospitalet
Oslo, Norway